Nothing Special   »   [go: up one dir, main page]

Rilstone, 2015 - Google Patents

Mutation in VMAT2 Causing a Pediatric Neurotransmitter Disease

Rilstone, 2015

View PDF
Document ID
441138024031040613
Author
Rilstone J
Publication year

External Links

Snippet

This thesis describes a new disease encompassing infantile-onset movement disorder (including severe parkinsonism and nonambulation), mood disturbance, autonomic instability, and developmental delay that was identified in eight cousins of a …
Continue reading at central.bac-lac.gc.ca (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
US12012634B2 (en) Methods for diagnosing, prognosing, and treating parkinson's disease or parkinsonism
US20230220468A1 (en) Methods for detecting a genetic variation in attractin-like 1 (atrnl1) gene in subject with parkinson's disease
US20230348981A1 (en) Methods and compositions for inhibiting and treating neurological conditions
Agrawal et al. The genetics of addiction—a translational perspective
Reif et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function
Haddley et al. Molecular genetics of monoamine transporters: relevance to brain disorders
Yamada et al. Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population
Asmus et al. Dystonia‐plus syndromes
Arinami Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia
Wakil et al. A novel splice site mutation in ERLIN2 causes hereditary spastic paraplegia in a Saudi family
Karpyak et al. Sequence variations of the human MPDZ gene and association with alcoholism in subjects with European ancestry
JP2007503210A (en) Human autism susceptibility genes and uses thereof
Poorkaj et al. A novel X‐linked four‐repeat tauopathy with Parkinsonism and spasticity
Rilstone Mutation in VMAT2 Causing a Pediatric Neurotransmitter Disease
Ichinose et al. DOPA-responsive dystonia
Sheerin The Use of Next Generation Sequencing Technologies to Dissect the Aetiologies of Parkinson’s disease and Dystonia
Schottlaender Genetic analysis of multiple system atrophy and related movement disorders
Kaivorinne Frontotemporal lobar degeneration in Finland: molecular genetics and clinical aspects
Arnold GENETICS OF OCD
Kinnear Molecular genetic strategies to identify Obsessive-compulsive disorder (OCD) and schizophrenia candidate genes in a South African sub-population group
Barr et al. XIII World Congress on Psychiatric Genetics 2005 Sponsored by
Rahman The brain as a drug target
Rao Sequence Variations in Four Disease‐associated Genes Display Potentially Altered Function for Psychiatric Disorders and Suicide Attempts in Chinese
NAGATSU et al. HIROSHI ICHINOSE
McKeane Identification of gene variants predisposing to schizophrenia and bipolar disease